The Pharmaceutical Industry and International Clinical Research: One Company’s Approach
dc.contributor.author | Clayman, M | |
dc.date.accessioned | 2006-05-09T17:09:06Z | |
dc.date.available | 2006-05-09T17:09:06Z | |
dc.date.issued | 2006-05-09T17:09:06Z | |
dc.description | Co-hosted by the IUPUI Office of International Affairs and the Indiana University Center for Bioethics. | en |
dc.description.abstract | Fifth lecture in a series: International Research Ethics, May 5, 2006. | en |
dc.description.sponsorship | Indiana University Center for Bioethics | en |
dc.format.extent | 91648 bytes | |
dc.format.mimetype | application/vnd.ms-powerpoint | |
dc.identifier.uri | https://hdl.handle.net/1805/566 | |
dc.language.iso | en_US | |
dc.subject | Indiana University School of Medicine | en |
dc.subject | Drugs Research | en |
dc.subject | Clinical trials -- United States | en |
dc.subject | Ethical issues in professional life | en |
dc.subject | Levine, Bob, -- 1944- | en |
dc.subject | Lilly Center (Eli Lilly and Company) | en |
dc.subject | Lilly Research Laboratories | en |
dc.subject | Meslin, Eric Mark | en |
dc.subject | Pharmacy Research | en |
dc.subject | Beauchamp, Tom L. | en |
dc.subject.lcsh | Ethics | |
dc.subject.lcsh | Bioethics | |
dc.subject.mesh | Clinical Trials | en |
dc.subject.mesh | Drug Industry | en |
dc.subject.mesh | Ethics, Clinical | en |
dc.subject.mesh | Ethics Committees | en |
dc.subject.mesh | Ethics, Research | en |
dc.subject.mesh | Ethical Review | en |
dc.subject.mesh | Human Experimentation | en |
dc.subject.nrcbl | Ethics | |
dc.subject.nrcbl | Bioethics Boards 2.4 | en |
dc.subject.nrcbl | Bioethics Commissions 2.4 | en |
dc.subject.nrcbl | Bioethics Councils 2.4 | en |
dc.subject.nrcbl | Bioethics, General 2.1 | en |
dc.subject.nrcbl | Bioethics Proceedings 2.3 | en |
dc.subject.nrcbl | Clinical Ethicists 9.6 | en |
dc.subject.nrcbl | Clinical Guidelines 9.8; 9.4 | en |
dc.subject.nrcbl | Clinical Trial Guidelines 18.2 | en |
dc.subject.nrcbl | Clinical Trials 18.2 | en |
dc.subject.nrcbl | Ethics Committees, National 2.4 | en |
dc.subject.nrcbl | Ethical Guidelines 6 | en |
dc.subject.nrcbl | Ethics in Scientific Research 1.3.9 | en |
dc.subject.nrcbl | International Affairs Ethics 1.3.6 | en |
dc.subject.nrcbl | International Aspects 21.1 | en |
dc.title | The Pharmaceutical Industry and International Clinical Research: One Company’s Approach | en |
dc.type | Presentation | en |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- OIA Speaker Series - International Clinical Research - Clayman - 5-5-06[1].ppt
- Size:
- 89.5 KB
- Format:
- Microsoft Powerpoint
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.83 KB
- Format:
- Item-specific license agreed upon to submission
- Description: